Naoki Fujitani Selected Research

Naoki Fujitani Research Topics

Disease

5	Neoplasms (Cancer) 11/2020 - 11/2008
3	Carcinoma (Carcinomatosis) 02/2013 - 11/2008
2	Mitochondrial Diseases (Mitochondrial Disease) 11/2020 - 10/2019
2	Infections 01/2019 - 09/2007
2	Alzheimer Disease (Alzheimer's Disease) 01/2015 - 08/2014
2	Neoplasm Metastasis (Metastasis) 01/2013 - 02/2011
2	Carcinogenesis 01/2013 - 02/2011
2	Inflammation (Inflammations) 01/2013 - 02/2011
2	Osteoarthritis 08/2012 - 01/2012
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2022
1	Body Weight (Weight, Body) 01/2019
1	Respiratory Syncytial Virus Infections 01/2019
1	Virus Diseases (Viral Diseases) 01/2019
1	Lipoma (Lipomata) 01/2019
1	Liposarcoma 01/2019
1	Neuroblastoma 01/2015
1	Rheumatoid Arthritis 01/2012
1	Experimental Arthritis 01/2012
1	Arthritis (Polyarthritis) 01/2012

Drug/Important Bio-Agent (IBA)

4	Polysaccharides (Glycans)IBA 02/2013 - 11/2008
3	Peptides (Polypeptides)IBA 01/2015 - 02/2011
3	Glycoproteins (Glycoprotein)IBA 02/2013 - 11/2008
2	Glutathione S-Transferase piIBA 11/2020 - 10/2019
2	Biological ProductsIBA 01/2019 - 01/2013
2	CytokinesIBA 01/2019 - 01/2012
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2013
2	Amyloid (Amyloid Fibrils)IBA 01/2015 - 08/2014
2	GlycosphingolipidsIBA 02/2013 - 08/2012
1	Tyrosine Kinase InhibitorsIBA 04/2022
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 04/2022
1	Glutathione Transferase (Glutathione S-Transferase)IBA 11/2020
1	EnzymesIBA 10/2019
1	O-(glucuronic acid 2-sulfate)-(1--3)-O-(2,5)-andydrotalitol 6-sulfateIBA 10/2019
1	Antineoplastic Agents (Antineoplastics)IBA 10/2019
1	AntioxidantsIBA 10/2019
1	Glutathione (Reduced Glutathione)IBA 10/2019
1	TransferasesIBA 10/2019
1	ParaffinIBA 01/2019
1	Formaldehyde (Formol)FDA Link 01/2019
1	ProteomeIBA 01/2019
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2019
1	Leucine (L-Leucine)FDA Link 01/2019
1	GlycosaminoglycansIBA 02/2013
1	OligosaccharidesIBA 02/2013
1	GlycopeptidesIBA 01/2013
1	EpitopesIBA 01/2013
1	alanyl-prolyl-glycineIBA 01/2013
1	prolyl-prolyl-alanineIBA 01/2013
1	histidylglycineIBA 01/2013
1	arginylprolineIBA 01/2013
1	alanylprolineIBA 01/2013
1	haematoside synthetaseIBA 01/2012
1	G(M3) GangliosideIBA 01/2012
1	InterleukinsIBA 01/2012
1	LectinsIBA 12/2011
1	MucinsIBA 02/2011
1	Uridine Diphosphate (UDP)IBA 02/2011
1	N-AcetylgalactosaminyltransferasesIBA 02/2011
1	Cisplatin (Platino)FDA LinkGeneric 11/2008
1	Indicators and Reagents (Reagents)IBA 11/2008
1	Cholera ToxinIBA 09/2007
1	peptide P3IBA 09/2007

Therapy/Procedure

2	Therapeutics 04/2022 - 10/2019
1	Oral Administration 01/2019